How will sleep medicine be affected by emerging digital health technologies, policies that govern their adoption and reimbursement, and the general increase in Americans’ awareness of the importance of sleep? ResMed (NYSE: RMD) leaders will answer these and other questions in Boston this week at the SLEEP conference, an annual gathering of roughly 5,000 physicians, researchers, sleep, allied health care professionals and more.
ResMed Chief Medical Officer Carlos M. Nunez, M.D., will discuss how digital health helps improve patient outcomes:
- Event: “Raw data, real insights: The impact on patient care”
- When: Monday, June 5, 12:45–1:45pm ET
- Where: Hynes Convention Center (900 Boylston St, Boston), Room 311
“ResMed digital health applications are clinically proven to improve patient adherence, particularly remote patient monitoring and self-monitoring tools,” said Nunez. “They are testaments to how the adoption and meaningful use of technology can benefit patients, physicians and providers everywhere.”
ResMed Vice President of Market Access Liesl Cooper, PhD, will speak on a panel about how delivering and tracking value-based sleep will be affected by both federal policies and general sleep awareness:
- Event: “Value-based sleep: Crucial conversations to define, demonstrate, and maximize our value”
- When: Tuesday, June 6, 2:45–4:45pm ET
- Where: Hynes Convention Center (900 Boylston St, Boston), Ballroom C
“Despite increasing awareness of the value of sleep, sleep disorders remain under-diagnosed and under-treated,” Cooper said. “To improve the value of sleep therapy, payer policies should enable diagnosis and treatment – and the use of digital technology to encourage adherence.”
About ResMed
ResMed (NYSE: RMD) changes lives with award-winning medical devices and cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 3 million patients remotely monitored every day. Our 5,000-strong team is committed to creating the world’s best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries. ResMed.com | Facebook | Twitter | LinkedIn
# # #
For media: Jayme Rubenstein, 858.836.6798, news@resmed.com
For investors: Agnes Lee, 858.836.5971, investorrelations@resmed.com